Back to ACAD
Atria Investments, Inc ACAD Position History
Acadia Pharmaceuticals Inc. • Healthcare
Quarters held
10
Latest value
$258K
Q3 2026
Peak value
$1.2M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $1.2M |
| Q3 2025 | $376K |
| Q4 2025 | $588K |
| Q4 2025 | $1M |
| Q1 2026 | $433K |
| Q1 2026 | $900K |
| Q2 2026 | $969K |
| Q2 2026 | $458K |
| Q3 2026 | $706K |
| Q3 2026 | $258K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $258K | 12.8K | — | — |
| Q3 2026 | $706K | 4.0K | — | — |
| Q2 2026 | $458K | 18.1K | — | — |
| Q2 2026 | $969K | 5.5K | — | — |
| Q1 2026 | $900K | 5.5K | — | — |
| Q1 2026 | $433K | 19.4K | — | — |
| Q4 2025 | $1M | 5.7K | — | — |
| Q4 2025 | $588K | 22.0K | — | — |
| Q3 2025 | $376K | 17.6K | — | — |
| Q3 2025 | $1.2M | 7.0K | — | — |
Other funds holding ACAD
$377M
$322.9M
$302.7M
$247.8M
$229.6M
$229.6M
$211.3M
$202.4M